Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Opipramol
Product Details | |
---|---|
Synonyms | NSC 169867; BRN 0627076; 2-{4-[3-(5H-Dibenzo[b,f]azepin-5-yl)propyl]-1-piperazinyl}ethanol |
Product Type | Chemical |
Properties | |
Formula |
C23H29N3O |
MW | 363.5 |
CAS | 315-72-0 |
RTECS | TL9100000 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥98% (HPLC) |
Appearance | Yellow powder. |
Solubility | Soluble in chloroform. |
Identity | Determined by NMR. |
Declaration | Manufactured by Chemodex. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | YNZFUWZUGRBMHL-UHFFFAOYSA-N |
Smiles | OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Tricyclic antidepressant and anxiolytic compound. Acts as a high affinity sigma receptor agonist, primarily at the σ1 subtype, but also at the σ2 subtype with somewhat lower affinity. Shows a low to moderate antagonistic affinity for the D2, 5-HT2, H1, H2, and muscarinic acetylcholine receptors. H1 and H2 receptor antagonism account for its antihistamine effects, and muscarinic acetylcholine receptor antagonism is responsible for its anticholinergic properties.
(1) T.S. Rao, et al.; Neuropharmacology. 29, 1191 (1990) | (2) T.S. Rao, et al.; Neuropharmacology. 29, 1199 (1990) | (3) H.J. Moller, et al.; J. Clin. Psychopharmacol. 21,59 (2001) | (4) G. Holoubek & W.E. Muller; J. Neural Transm. 110, 1169 (2003) | (5) W.E. Muller, et al.; Pharmacopsychiatry 37, S189 (2004)